Founded in 2021, Planetary develops and operates a proprietary full-stack platform for bioprocess design, scale-up and industrial fermentation via its BioBlocks system. The company builds, owns and operates fermentation facilities to produce bio-based proteins, fibres and enzymes and pursues an IP-rich licensing strategy with agro-industrial partners, particularly sugar companies. Planetary has commercial traction through product launches under its B2B brand Libre®, including a nationwide mycoprotein filet launch with ALDI Suisse at price parity. It operates industrial-scale production in Aarberg, Switzerland and is scaling sugar-to-protein upcycling technology globally, targeting ultra-low-cost mycoprotein production below €0.85/kg in collaborations with partners in sucrose-rich regions. Planetary is rolling out additional launches across alternative meat and dairy, meat hybrids, fibre-rich products and protein fortification applications. The company plans to expand its global commercial rollout and technology licensing efforts using the newly raised capital.

Total raised

$35M

Funding rounds

3

Latest round

Series A

Latest activity

Apr 2026